Your browser doesn't support javascript.
loading
Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity.
Lee, Wongeun; Kim, Dong Kwon; Synn, Chun-Bong; Lee, Hee Kyu; Park, Sungho; Jung, Dong-Sik; Choi, Yewon; Kim, Jae Hwan; Byeon, Youngseon; Kim, Young Seob; Lee, Seul; Lee, Soyeon; Joo, Yunjoo; Lee, Eun Ji; Yun, Mi Ran; Heo, Seong Gu; Yang, Wookyeom; Jung, Ji Eun; Kim, Eun Kyung; Park, Jooyeon; Park, June Dong; Lee, Doo Jae; Kim, Hyeon-Woo; Lim, Sun Min; Hong, Min Hee; Ahn, Beung-Chul; Lee, Jii Bum; Pyo, Kyoung-Ho.
Afiliação
  • Lee W; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.
  • Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Synn CB; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee HK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Park S; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.
  • Jung DS; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.
  • Choi Y; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.
  • Kim JH; Department of Discovery Biology, Oscotec Inc., Seongnam, South Korea.
  • Byeon Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Joo Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee EJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Yun MR; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Heo SG; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.
  • Yang W; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Jung JE; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim EK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Park J; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Park JD; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee DJ; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.
  • Kim HW; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.
  • Lim SM; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.
  • Hong MH; Wide River Institute of Immunology, Seoul National University, Hongcheon, South Korea.
  • Ahn BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Lee JB; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Pyo KH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Front Oncol ; 12: 821391, 2022.
Article em En | MEDLINE | ID: mdl-35356198
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article